Novel peptide-based oncolytic vaccine for enhancement of adaptive antitumor immune response via co-engagement of innate Fcγ and Fcα receptors

Novel peptide-based oncolytic vaccine for enhancement of adaptive antitumor immune response via co-engagement of innate Fcγ and Fcα receptors

Background Cancer immunotherapy relies on using the immune system to recognize and eradicate cancer cells. Adaptive immunity, which consists of mainly antigen-specific cytotoxic T cells, plays a pivotal role in controlling cancer progression. However, innate immunity is a necessary component of the...

Full description

Bibliographic Details
Main Authors: Sari Pesonen, Sara Feola, Manlio Fusciello, Vincenzo Cerullo, Firas Hamdan, Jacopo Chiaro, Michaela Feodoroff, Gabriella Antignani, Salvatore Russo, Jeanette Leusen, Mikaela Grönholm, Federica D'Alessio, Riikka Mölsä, Virpi Stigzelius, Paolo Bottega
Format: Article
Language:English
Published: BMJ Publishing Group 2024-03-01
Series:Journal for ImmunoTherapy of Cancer
Online Access:https://jitc.bmj.com/content/12/3/e008342.full

Internet

https://jitc.bmj.com/content/12/3/e008342.full

Similar Items